2,7-naphthyridinone-based MET kinase inhibitors: A promising novel scaffold for antitumor drug development

Published 2019 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
2,7-naphthyridinone-based MET kinase inhibitors: A promising novel scaffold for antitumor drug development
Authors
Keywords
2,7-Naphthyridone, MET kinase inhibitor, Antitumor, In vivo efficacy
Journal
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
Volume 178, Issue -, Pages 705-714
Publisher
Elsevier BV
Online
2019-06-16
DOI
10.1016/j.ejmech.2019.06.033

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.